KZR logo

Kezar Life Sciences (KZR) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$35.49 M
-$4.96 M-12.27%

December 31, 2023


Summary


Performance

KZR Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKZRbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$34.86 M
+$6.58 M+23.28%

September 30, 2024


Summary


Performance

KZR Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKZRbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

KZR Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.3%0.0%
3 y3 years+67.2%0.0%
5 y5 years+46.8%0.0%

KZR Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-43.6%at low-66.9%+31.6%
5 y5-year-43.6%+137.4%-66.9%+171.6%
alltimeall time-43.6%+264.1%-66.9%+171.6%

Kezar Life Sciences Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$34.86 M(+23.3%)
Jun 2024
-
$28.28 M(-14.4%)
Mar 2024
-
$33.03 M(-6.9%)
Dec 2023
$35.49 M(-12.3%)
$35.49 M(+33.9%)
Sep 2023
-
$26.50 M(-5.7%)
Jun 2023
-
$28.11 M(-22.2%)
Mar 2023
-
$36.13 M(-10.7%)
Dec 2022
$40.46 M(-35.7%)
$40.46 M(-37.2%)
Sep 2022
-
$64.45 M(-38.8%)
Jun 2022
-
$105.39 M(+170.9%)
Mar 2022
-
$38.91 M(-38.1%)
Dec 2021
$62.88 M
$62.88 M(+10.1%)
Sep 2021
-
$57.09 M(+116.4%)
Jun 2021
-
$26.38 M(+15.2%)
DateAnnualQuarterly
Mar 2021
-
$22.91 M(+7.9%)
Dec 2020
$21.23 M(+42.0%)
$21.23 M(+65.4%)
Sep 2020
-
$12.83 M(-25.8%)
Jun 2020
-
$17.30 M(-15.9%)
Mar 2020
-
$20.57 M(+37.6%)
Dec 2019
$14.95 M(-38.2%)
$14.95 M(-26.6%)
Sep 2019
-
$20.36 M(+56.3%)
Jun 2019
-
$13.03 M(-29.4%)
Mar 2019
-
$18.47 M(-23.6%)
Dec 2018
$24.18 M(-52.6%)
$24.18 M(-38.9%)
Sep 2018
-
$39.59 M(-61.2%)
Jun 2018
-
$101.97 M(+116.6%)
Mar 2018
-
$47.09 M(-7.7%)
Dec 2017
$51.03 M(+423.6%)
$51.03 M
Dec 2016
$9.75 M
-

FAQ

  • What is Kezar Life Sciences annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Kezar Life Sciences?
  • What is Kezar Life Sciences annual cash & cash equivalents year-on-year change?
  • What is Kezar Life Sciences quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Kezar Life Sciences?
  • What is Kezar Life Sciences quarterly cash and cash equivalents year-on-year change?

What is Kezar Life Sciences annual cash & cash equivalents?

The current annual cash & cash equivalents of KZR is $35.49 M

What is the all time high annual cash & cash equivalents for Kezar Life Sciences?

Kezar Life Sciences all-time high annual cash & cash equivalents is $62.88 M

What is Kezar Life Sciences annual cash & cash equivalents year-on-year change?

Over the past year, KZR annual cash & cash equivalents has changed by -$4.96 M (-12.27%)

What is Kezar Life Sciences quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of KZR is $34.86 M

What is the all time high quarterly cash and cash equivalents for Kezar Life Sciences?

Kezar Life Sciences all-time high quarterly cash and cash equivalents is $105.39 M

What is Kezar Life Sciences quarterly cash and cash equivalents year-on-year change?

Over the past year, KZR quarterly cash and cash equivalents has changed by $0.00 (0.00%)